EARNEST PARTNERS LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
EARNEST PARTNERS LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,758
+5.9%
310.0%0.00%
Q2 2023$3,550
-16.9%
310.0%0.00%
Q1 2023$4,273
+6.4%
310.0%0.00%
Q4 2022$4,017
+33.9%
310.0%0.00%
Q3 2022$3,000
+50.0%
310.0%0.00%
Q2 2022$2,0000.0%310.0%0.00%
Q1 2022$2,000
-33.3%
310.0%0.00%
Q4 2021$3,0000.0%310.0%0.00%
Q3 2021$3,000
+50.0%
310.0%0.00%
Q2 2021$2,0000.0%310.0%0.00%
Q1 2021$2,000
-60.0%
310.0%0.00%
Q4 2020$5,000
+25.0%
310.0%0.00%
Q3 2020$4,000
-20.0%
310.0%0.00%
Q2 2020$5,000
+66.7%
310.0%0.00%
Q1 2020$3,000
-25.0%
310.0%0.00%
Q4 2019$4,000
+100.0%
310.0%0.00%
Q3 2019$2,000
-60.0%
310.0%0.00%
Q2 2019$5,000
+25.0%
310.0%0.00%
Q1 2019$4,000
+33.3%
310.0%0.00%
Q4 2018$3,000
-40.0%
310.0%0.00%
Q3 2018$5,000
+25.0%
310.0%0.00%
Q2 2018$4,000310.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders